000 | 01999 a2200589 4500 | ||
---|---|---|---|
005 | 20250515032700.0 | ||
264 | 0 | _c20061122 | |
008 | 200611s 0 0 eng d | ||
022 | _a0899-9007 | ||
024 | 7 |
_a10.1016/j.nut.2006.03.014 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSakurai, Yoichi | |
245 | 0 | 0 |
_aEffects of long-term continuous use of immune-enhancing enteral formula on nutritional and immunologic status in non-surgical patients. _h[electronic resource] |
260 |
_bNutrition (Burbank, Los Angeles County, Calif.) _c |
||
300 |
_a713-21 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Randomized Controlled Trial | ||
650 | 0 | 4 |
_a8,11,14-Eicosatrienoic Acid _xblood |
650 | 0 | 4 |
_aArginine _xblood |
650 | 0 | 4 | _aB-Lymphocytes |
650 | 0 | 4 | _aBlood Urea Nitrogen |
650 | 0 | 4 | _aCD4-CD8 Ratio |
650 | 0 | 4 |
_aDocosahexaenoic Acids _xblood |
650 | 0 | 4 |
_aEicosapentaenoic Acid _xblood |
650 | 0 | 4 |
_aEnteral Nutrition _xadverse effects |
650 | 0 | 4 | _aFood, Formulated |
650 | 0 | 4 | _aGastrostomy |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aImmunity |
650 | 0 | 4 |
_aInsulin-Like Growth Factor I _xanalysis |
650 | 0 | 4 |
_aInterleukin-10 _xblood |
650 | 0 | 4 |
_aKiller Cells, Natural _ximmunology |
650 | 0 | 4 | _aLymphocyte Count |
650 | 0 | 4 | _aNutritional Status |
650 | 0 | 4 |
_aOrnithine _xblood |
650 | 0 | 4 | _aProspective Studies |
650 | 0 | 4 | _aT-Lymphocytes |
650 | 0 | 4 |
_aUric Acid _xblood |
700 | 1 | _aOh-Oka, Yuriko | |
700 | 1 | _aKato, Shiho | |
700 | 1 | _aSuzuki, Sadamu | |
700 | 1 | _aHayakawa, Mariko | |
700 | 1 | _aMasui, Toshihiko | |
700 | 1 | _aYoshida, Ikuo | |
700 | 1 | _aTonomura, Shuhei | |
700 | 1 | _aMitsutaka, Shoji | |
700 | 1 | _aNakamura, Yasuko | |
700 | 1 | _aUyama, Ichiro | |
700 | 1 | _aKomori, Yoshiyuki | |
700 | 1 | _aOchiai, Masahiro | |
773 | 0 |
_tNutrition (Burbank, Los Angeles County, Calif.) _gvol. 22 _gno. 7-8 _gp. 713-21 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.nut.2006.03.014 _zAvailable from publisher's website |
999 |
_c16407960 _d16407960 |